HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robotic unclamped "minimal-margin" partial nephrectomy: ongoing refinement of the anatomic zero-ischemia concept.

AbstractBACKGROUND:
Anatomic partial nephrectomy (PN) techniques aim to decrease or eliminate global renal ischemia.
OBJECTIVE:
To report the technical feasibility of completely unclamped "minimal-margin" robotic PN. We also illustrate the stepwise evolution of anatomic PN surgery with related outcomes data.
DESIGN, SETTING, AND PARTICIPANTS:
This study was a retrospective analysis of 179 contemporary patients undergoing anatomic PN at a tertiary academic institution between October 2009 and February 2013. Consecutive consented patients were grouped into three cohorts: group 1, with superselective clamping and developmental-curve experience (n = 70); group 2, with superselective clamping and mature experience (n = 60); and group 3, which had completely unclamped, minimal-margin PN (n = 49).
SURGICAL PROCEDURE:
Patients in groups 1 and 2 underwent superselective tumor-specific devascularization, whereas patients in group 3 underwent completely unclamped minimal-margin PN adjacent to the tumor edge, a technique that takes advantage of the radially oriented intrarenal architecture and anatomy.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:
Primary outcomes assessed the technical feasibility of robotic, completely unclamped, minimal-margin PN; short-term changes in estimated glomerular filtration rate (eGFR); and development of new-onset chronic kidney disease (CKD) stage >3. Secondary outcome measures included perioperative variables, 30-d complications, and histopathologic outcomes.
RESULTS AND LIMITATIONS:
Demographic data were similar among groups. For similarly sized tumors (p = 0.13), percentage of kidney preserved was greater (p = 0.047) and margin width was narrower (p = 0.0004) in group 3. In addition, group 3 had less blood loss (200, 225, and 150ml; p = 0.04), lower transfusion rates (21%, 23%, and 4%; p = 0.008), and shorter hospital stay (p = 0.006), whereas operative time and 30-d complication rates were similar. At 1-mo postoperatively, median percentage reduction in eGFR was similar (7.6%, 0%, and 3.0%; p = 0.53); however, new-onset CKD stage >3 occurred less frequently in group 3 (23%, 10%, and 2%; p = 0.003). Study limitations included retrospective analysis, small sample size, and short follow-up.
CONCLUSIONS:
We developed an anatomically based technique of robotic, unclamped, minimal-margin PN. This evolution from selective clamped to unclamped PN may further optimize functional outcomes but requires external validation and longer follow-up.
PATIENT SUMMARY:
The technical evolution of partial nephrectomy surgery is aimed at eliminating global renal damage from the cessation of blood flow. An unclamped minimal-margin technique is described and may offer renal functional advantage but requires long-term follow-up and validation at other institutions.
AuthorsRaj Satkunasivam, Sheaumei Tsai, Sumeet Syan, Jean-Christophe Bernhard, Andre Luis de Castro Abreu, Sameer Chopra, Andre K Berger, Dennis Lee, Andrew J Hung, Jie Cai, Mihir M Desai, Inderbir S Gill
JournalEuropean urology (Eur Urol) Vol. 68 Issue 4 Pg. 705-12 (Oct 2015) ISSN: 1873-7560 [Electronic] Switzerland
PMID26071789 (Publication Type: Journal Article)
CopyrightCopyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Renal Cell (blood supply, pathology, surgery)
  • Constriction
  • Feasibility Studies
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Ischemia
  • Kidney Neoplasms (blood supply, pathology, surgery)
  • Length of Stay
  • Male
  • Middle Aged
  • Nephrectomy (adverse effects, methods)
  • Operative Time
  • Renal Artery (physiopathology, surgery)
  • Renal Circulation
  • Renal Insufficiency, Chronic (etiology, physiopathology)
  • Retrospective Studies
  • Risk Factors
  • Robotic Surgical Procedures
  • Time Factors
  • Treatment Outcome
  • Tumor Burden
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: